<DOC>
	<DOCNO>NCT01206439</DOCNO>
	<brief_summary>The purpose study determine Nebivolol effect heart function determine change echocardiographic data exercise tolerance .</brief_summary>
	<brief_title>An Advanced Echocardiographic Evaluation Nebivolol</brief_title>
	<detailed_description>Subjects give either 5 10 mg daily oral Nebivolol blood pressure control . They undergo stress echocardiography baseline , day 14 , 90 180 .</detailed_description>
	<mesh_term>Nebivolol</mesh_term>
	<criteria>1 . Diagnosis hypertension 2 . Written inform consent initiation study related procedure 3 . Baseline Blood pressure &gt; 140 systolic &gt; 90 diastolic antihypertensive therapy . 4 . Currently take one antihypertensive one antihypertensive one diuretic treatment hypertension . 1 . Physical limitation result limited ability walk treadmill stress echo 2 . Intolerance beta blocker 3 . On one medication treatment hypertension unless second medication diuretic . 4 . Currently pregnant breast feeding . 5 . LFT &gt; 3 X ULN 6 . HgA1C &gt; 7 7 . Participation clinical research study involve evaluation investigational drug device within past 30 day enrollment 8 . Unwilling follow protocol return study relate procedure . 9 . Any following condition : Coronary artery disease Heart failure Valvular heart disease Ischemic heart disease Atrial fibrillation Pacemaker ICD Hyperlipidemia Diabetes Mellitus Stroke/TIA Anemia COPD Asthma Renal failure require dialysis Liver failure Cirrhosis Thyroid dysfunction 10 . Any medical condition PI 's opinion could affect myocardial function . 11 . Current ETOH illicit drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>